Colon cancer cells: pro-invasive signalling

Area of Science:

• Gastroenterology
• Oncology
• Microbiology

Background:

• Colon cancer involves abnormal renewal of the enteric epithelium, leading to uncontrolled cell proliferation and invasion.
• E-cadherin plays a role in suppressing invasion, and its dysfunction contributes to colon cancer progression.
• Enteric bacteria, including Listeria monocytogenes, are implicated in stimulating cancer cell invasion.

Purpose of the Study:

• To investigate the role of enteric bacteria and their products in colon cancer cell invasion.
• To identify the molecular mechanisms by which bacterial peptides promote invasion.
• To explore the potential therapeutic implications of targeting these pathways.

Main Methods:

• Analysis of colon cancer cell renewal and invasion processes.
• Investigation of Listeria monocytogenes and other enteric bacteria.
• Identification and characterization of a beta-casein-derived peptide.
• Study of signaling pathways involving small guanosine triphosphatases and the delta opioid receptor.
• Testing the effect of naloxone, a delta opioid receptor antagonist.

Main Results:

• Enteric bacteria produce a 13-amino acid peptide that stimulates colon cancer cell invasion.
• This peptide signals through small guanosine triphosphatases, affecting the actin cytoskeleton.
• The peptide also signals via phosphorylation of the delta opioid receptor.
• Naloxone effectively neutralizes the pro-invasive activity of the peptide.

Conclusions:

• A bacterial peptide derived from beta-casein promotes colon cancer invasion.
• The delta opioid receptor is involved in mediating the pro-invasive effects of this peptide.
• Opioids may play a significant role in colon cancer malignancy and invasion.